Aptose Biosciences Net Tangible Assets

Aptose Biosciences (APTO) currently reports a net tangible assets of $-35M as of March 2026. That compares with $-7.4M in the prior-year period — down 369.0% year over year. Use the charts on this page to explore Aptose Biosciences's net tangible assets history and peer comparisons.

Aptose Biosciences's net tangible assets decreased from $-7.4M to $-35M — a 369.0% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Aptose Biosciences reported $-35M in net tangible assets as of March 2026. That compares with $-7.4M in the prior-year period — down 369.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $-35M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Aptose Biosciences, and consider following APTO for alerts when major investors trade the stock.

Aptose Biosciences is classified in the Healthcare sector. On net tangible assets, it currently shows $-35M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing APTO with unrelated industries.